Assessing recurrence risk following intraperitoneal chemotherapy for ovarian cancer: A day late and a dollar short?

por Leath, Charles A., Hamilton, Chad A.
Publicado 2019

Current Approaches and Challenges in Managing and Monitoring Treatment Response in Ovarian Cancer

por Marcus, Charlotte S, Maxwell, G Larry, Darcy, Kathleen M, Hamilton, Chad A, McGuire, William P
Publicado 2014

Progesterone and calcitriol reduce invasive potential of endometrial cancer cells by targeting ARF6, NEDD9 and MT1-MMP

por Waheed, Sana, Dorjbal, Batsukh, Hamilton, Chad A., Maxwell, G. Larry, Rodriguez, Gustavo C., Syed, Viqar
Publicado 2017

Nestin suppression attenuates invasive potential of endometrial cancer cells by downregulating TGF-β signaling pathway

por Bokhari, Amber A., Baker, Tabari M., Dorjbal, Batsukh, Waheed, Sana, Zahn, Christopher M., Hamilton, Chad A., Maxwell, G. Larry, Syed, Viqar
Publicado 2016

Progesterone potentiates the growth inhibitory effects of calcitriol in endometrial cancer via suppression of CYP24A1

por Bokhari, Amber A., Lee, Laura R., Raboteau, Dewayne, Turbov, Jane, Rodriguez, Isabel V., Pike, John Wesley, Hamilton, Chad A., Maxwell, George Larry, Rodriguez, Gustavo C., Syed, Viqar
Publicado 2016

NUAK1 (ARK5) Is Associated with Poor Prognosis in Ovarian Cancer

por Phippen, Neil T., Bateman, Nicholas W., Wang, Guisong, Conrads, Kelly A., Ao, Wei, Teng, Pang-ning, Litzi, Tracy A., Oliver, Julie, Maxwell, G. Larry, Hamilton, Chad A., Darcy, Kathleen M., Conrads, Thomas P.
Publicado 2016

Gene Expression Analysis of Early Stage Endometrial Cancers Reveals Unique Transcripts Associated with Grade and Histology but Not Depth of Invasion

por Risinger, John I., Allard, Jay, Chandran, Uma, Day, Roger, Chandramouli, Gadisetti V. R., Miller, Caela, Zahn, Christopher, Oliver, Julie, Litzi, Tracy, Marcus, Charlotte, Dubil, Elizabeth, Byrd, Kevin, Cassablanca, Yovanni, Becich, Michael, Berchuck, Andrew, Darcy, Kathleen M., Hamilton, Chad A., Conrads, Thomas P., Maxwell, G. Larry
Publicado 2013

Jupiter microtubule‐associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers

por Bateman, Nicholas W., Teng, Pang‐Ning, Hope, Erica, Hood, Brian L., Oliver, Julie, Ao, Wei, Zhou, Ming, Wang, Guisong, Tommarello, Domenic, Wilson, Katlin, Litzy, Tracy, Conrads, Kelly A., Hamilton, Chad A., Darcy, Kathleen M., Casablanca, Yovanni, Maxwell, George Larry, Bae‐Jump, Victoria, Conrads, Thomas P.
Publicado 2019

Final analysis of a phase I/IIa trial of the folate‐binding protein‐derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients

por Brown, Tommy A., Byrd, Kevin, Vreeland, Timothy J., Clifton, Guy T., Jackson, Doreen O., Hale, Diane F., Herbert, Garth S., Myers, John W., Greene, Julia M., Berry, John S., Martin, Jonathan, Elkas, John C., Conrads, Thomas P., Darcy, Kathleen M., Hamilton, Chad A., Maxwel, George L., Peoples, George E.
Publicado 2019

Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients

por Jackson, Doreen O., Byrd, Kevin, Vreeland, Timothy J., Hale, Diane F., Herbert, Garth S., Greene, Julia M., Schneble, Erika J., Berry, John S., Trappey, Alfred F., Travis Clifton, Guy, Hardin, Mark O., Martin, Jonathan, Elkas, John C., Conrads, Thomas P., Darcy, Kathleen M., Hamilton, Chad A., Maxwell, George L., Peoples, George E.
Publicado 2016

Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients

por Bateman, Nicholas W., Tarney, Christopher M., Abulez, Tamara, Soltis, Anthony R., Zhou, Ming, Conrads, Kelly, Litzi, Tracy, Oliver, Julie, Hood, Brian, Driggers, Paul, Viollet, Coralie, Dalgard, Clifton, Wilkerson, Matthew, Catherino, William, Hamilton, Chad A., Darcy, Kathleen M., Casablanca, Yovanni, Al-Hendy, Ayman, Segars, James, Conrads, Thomas P., Larry Maxwell, G.
Publicado 2021

Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine Cancer

por Kucera, Calen W., Tian, Chunqiao, Tarney, Christopher M., Presti, Cassandra, Jokajtys, Suzanne, Winkler, Stuart S., Casablanca, Yovanni, Bateman, Nicholas W., Mhawech-Fauceglia, Paulette, Wenzel, Lari, Hamilton, Chad A., Chan, John K., Jones, Nathaniel L., Rocconi, Rodney P., O’Connor, Timothy D., Farley, John H., Shriver, Craig D., Conrads, Thomas P., Phippen, Neil T., Maxwell, G. Larry, Darcy, Kathleen M.
Publicado 2023

Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study

por Casablanca, Yovanni, Wang, Guisong, Lankes, Heather A., Tian, Chunqiao, Bateman, Nicholas W., Miller, Caela R., Chappell, Nicole P., Havrilesky, Laura J., Wallace, Amy Hooks, Ramirez, Nilsa C., Miller, David S., Oliver, Julie, Mitchell, Dave, Litzi, Tracy, Blanton, Brian E., Lowery, William J., Risinger, John I., Hamilton, Chad A., Phippen, Neil T., Conrads, Thomas P., Mutch, David, Moxley, Katherine, Lee, Roger B., Backes, Floor, Birrer, Michael J., Darcy, Kathleen M., Maxwell, George Larry
Publicado 2022